HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $513,025 | -8.7% | 5,727 | -13.2% | 0.09% | -12.9% |
Q2 2023 | $561,924 | +88.7% | 6,600 | +83.4% | 0.10% | +62.9% |
Q1 2023 | $297,817 | +3.4% | 3,599 | -1.7% | 0.06% | +1.6% |
Q4 2022 | $288,095 | -15.3% | 3,663 | -28.1% | 0.06% | -47.0% |
Q2 2021 | $340,000 | +9.0% | 5,096 | +81.5% | 0.12% | -24.3% |
Q1 2021 | $312,000 | – | 2,807 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |